On November 26, 2019 BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, reported it has been invited to present at the following two investor conferences in December (Press release, Biolase Technology, NOV 26, 2019, View Source [SID1234551737]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

8th Annual Benchmark Discovery One-on-One Conference
Wednesday, December 4, 2019
The New York Athletic Club
New York City

12th Annual LD Micro Main Event
Wednesday, December 11, 2019 at 11:40 am PT (formal presentation and one-on-one meetings)
Luxe Sunset Boulevard Hotel
Los Angeles, CA

BIOLASE President and CEO Todd Norbe and Executive Vice President and CFO John Beaver will present and/or host one-on-one and small group meetings with investors at these conferences. Meetings can be scheduled through the firms hosting the conferences or through BIOLASE’s investor relations firm, EVC Group LLC (contact information below).

To access the live webcast or replay of the formal presentation at the LD Micro conference, visit the investor relations section of the company’s website at www.biolase.com.